81
ROBERTSON, D. Contraindication to the use of ocular phenylephrine in idiopathic
orthostatic hypotension. Am. J. Opthalmol., v. 87, p. 819-822, 1979.
ROSALES, T.; ISENBERG, S.; LEAKE, R.; EVERETT, S. Systemic effects of
mydriatics in low-weight infants. J. Pediatr. Ophthalmol. Strabismus, v. 18, p. 42-
44, 1981.
SHELL, J. W. Pharmacokinetics of topically applied ophthalmic drugs. Surv.
Ophthalmol., v. 26, p. 207-218, 1982.
SMITH R. B.; READ, S.; OCZYPOK, P. M. Mydriatic effect of phenylephrine. Ear
Nose Throat Mon., v. 55, p. 36-37, 1976.
SOLOSKO, D.; SMITH, R. B. Hypertension following 10 percent phenylephrine
ophthalmic. Anesthesiology, v. 36, p. 187, 1972.
STEVENS, R. J.; COLEMAN, R. L.; ADLER, A. I.; STRATTON, I. M.; MATTHEWS,
D. R.; HOLMAN R. R. Risk factors for myocardial infarction case fatality and stroke
case fatality in type 2 diabetes (UKPDS 66). Diabetes Care, v. 27, p. 201-207, 2004.
STEVENS, R. J.; KOTHARI, V.; ADLER, A. I.; STRATTON, I. M.; UNITED KIGDOM
PROSPECTIVE DIABETES STUDY (UKPDS) GROUP. The UKPDS risk engine: a
model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin.
Sci., v. 101, p. 671-679, 2001.
STRATTON, I. M.; ADLER, A. I.; NEIL, H. A.; MATTHEWS, D. R.; MANLEY, S. E.;
CULL, C. A.; HADDEN, D.; TURNER, R.C.; HOLMAN, R. R. Association of
glycaemia with macrovascular and microvascular complications of type 2 diabetes
(UKPDS 35): prospective observational study. BMJ, v. 321, p. 405-412, 2000.
TAKATA, S.; OGAWA, J.; MAENO, K.; IGARASHI, A.; TERASAKI, T.; IKEDA, T.;
HATTORI, N. Effects of atropine on adrenergic responsiveness and reflex
vasoconstriction in humans. Clin. Exp. Hypertens. A., v. 11, p. 295-301, 1989.
TANNER, V.; CASSWELL, A. G. A comparative study of the efficacy of 2.5%
phenylephrine and 10% phenylephrine in pre-operative mydriasis for routine cataract
surgery. Eye, v. 11, p. 946-948, 1997.
VILELA, M. A. P.; CORRÊA-MEYER, G. S.; CORRÊA-MEYER, R. M. O exame
angiográfico: histórico, finalidades, fundamentos, complicações e noções
anatômicas. In: VILELA, M. A. P. Angiografia fluoresceínica: atlas & texto. 2. ed.
Rio de Janeiro: Cultura Médica, 2005. cap. 1, p. 1-13.
WEISS, J. S.; WEISS, J. N.; GREENFIELD, D. S. The effects of phenylephrine 2.5%
versus phenylephrine 10% on pupillary dilation in patients with diabetes. Retina, v.
15, p. 130-133, 1995.
WESLEY, R. E. Phenylephrine eyedrops and cardiovascular accidents after
fluorescein angiography. J. Ocular Ther. Surg., v. 2, p. 212-214, 1983.
WESLEY, R. E.; BLOUNT, W. C.; ARTERBERRY, J. F. Acute myocardial infarction
after fluorescein angiography. Am. J. Opthalmol., v. 87, p. 834-835, 1979.